ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
tonks306511
|
655 |
234K |
4 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
655
|
234K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
tonks306511
|
555 |
219K |
14 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
555
|
219K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
tonks306511
|
2.2K |
742K |
9 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
2.2K
|
742K
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
22K |
7.7M |
9 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
22K
|
7.7M
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
tonks306511
|
905 |
270K |
6 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
905
|
270K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
tonks306511
|
905 |
270K |
9 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
905
|
270K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
tonks306511
|
905 |
270K |
5 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
270K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
tonks306511
|
905 |
270K |
6 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
270K
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
22K |
7.7M |
2 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
22K
|
7.7M
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
4.0M |
10 |
19/07/24 |
19/07/24 |
General
|
11K
|
4.0M
|
10
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
4.0M |
29 |
19/07/24 |
19/07/24 |
General
|
11K
|
4.0M
|
29
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
tonks306511
|
911 |
317K |
1 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
911
|
317K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
tonks306511
|
911 |
317K |
0 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
911
|
317K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
tonks306511
|
911 |
317K |
2 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
911
|
317K
|
2
|
|
ASX - By Stock
|
PH2 |
Re:
Ann: Responses to ASX Query Letters
|
|
tonks306511
|
3 |
1.3K |
3 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
3
|
1.3K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
tonks306511
|
146 |
44K |
8 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
44K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
tonks306511
|
911 |
317K |
8 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
911
|
317K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
tonks306511
|
911 |
317K |
16 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
911
|
317K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
tonks306511
|
391 |
81K |
15 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
81K
|
15
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
tonks306511
|
555 |
219K |
7 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
555
|
219K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
tonks306511
|
391 |
81K |
8 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
81K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
tonks306511
|
391 |
81K |
2 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
81K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notification regarding unquoted securities - PER
|
|
tonks306511
|
87 |
20K |
7 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
87
|
20K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
tonks306511
|
168 |
47K |
2 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
47K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
tonks306511
|
168 |
47K |
8 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
47K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
tonks306511
|
168 |
47K |
3 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
47K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
tonks306511
|
168 |
47K |
4 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
47K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
tonks306511
|
1.2K |
315K |
3 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
1.2K
|
315K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
tonks306511
|
1.2K |
315K |
2 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
1.2K
|
315K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
tonks306511
|
26K |
12M |
1 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
26K
|
12M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
tonks306511
|
26K |
12M |
3 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
26K
|
12M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
tonks306511
|
2.2K |
742K |
7 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
2.2K
|
742K
|
7
|
|
ASX - By Stock
|
PER |
Re:
FDA approves Sareptas Srp901 for the whole population
|
|
tonks306511
|
63 |
19K |
6 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
63
|
19K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
tonks306511
|
911 |
317K |
2 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
911
|
317K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
tonks306511
|
80 |
25K |
0 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
80
|
25K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
tonks306511
|
80 |
25K |
4 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
80
|
25K
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
22K |
7.7M |
4 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
22K
|
7.7M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
tonks306511
|
2.2K |
742K |
18 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2.2K
|
742K
|
18
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
tonks306511
|
655 |
234K |
19 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
655
|
234K
|
19
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
22K |
7.7M |
1 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
22K
|
7.7M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
22K |
7.7M |
6 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
22K
|
7.7M
|
6
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
tonks306511
|
2.2K |
771K |
9 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
2.2K
|
771K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
tonks306511
|
1.0K |
306K |
5 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
306K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Dr Daniel Tillett appointed CEO of Race Oncology
|
|
tonks306511
|
120 |
35K |
7 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
120
|
35K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
tonks306511
|
2.9K |
1.0M |
41 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
41
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
tonks306511
|
129 |
36K |
2 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
129
|
36K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity Confirms No Supply Disruptions for Clinical Trials
|
|
tonks306511
|
11 |
4.7K |
6 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
11
|
4.7K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
tonks306511
|
655 |
234K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
655
|
234K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Application for quotation of securities - CU6
|
|
tonks306511
|
1 |
810 |
2 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1
|
810
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
tonks306511
|
238 |
66K |
21 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
238
|
66K
|
21
|
|